ARCHIVES

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.

January 25, 2002

Abstracts From AACR Annual Meeting

June 4, 1976

FDA Approves Generic Capecitabine

September 20, 2013

NCI-Approved Clinical Trials

November 26, 2004

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999

ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures

March 29, 1985